LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.79 | 27.76 | 920 | 1605 | 0.5732 | 0.8186 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.79 | 27.76 | 52 | 1605 | 0.0324 | 0.1132 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 25.79 | 27.76 | 1066 | 1605 | 0.6641 | 0.8649 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.49 | 27.76 | 20 | 1723 | 0.0116 | -0.0536 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.49 | 27.76 | 922 | 1723 | 0.5351 | 0.8007 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.49 | 27.76 | 57 | 1723 | 0.0331 | 0.1284 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.49 | 27.76 | 1092 | 1723 | 0.6337 | 0.8526 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.19 | 27.76 | 24 | 1863 | 0.0129 | -0.0237 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.19 | 27.76 | 941 | 1863 | 0.5051 | 0.7871 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.19 | 27.76 | 59 | 1863 | 0.0317 | 0.1323 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.19 | 27.76 | 1093 | 1863 | 0.5866 | 0.8317 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.90 | 27.76 | 22 | 2032 | 0.0108 | -0.0368 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.90 | 27.76 | 942 | 2032 | 0.4635 | 0.7665 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.90 | 27.76 | 60 | 2032 | 0.0295 | 0.1325 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 30.90 | 27.76 | 1099 | 2032 | 0.5408 | 0.8110 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.60 | 27.76 | 30 | 2235 | 0.0134 | 0.0123 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.60 | 27.76 | 960 | 2235 | 0.4294 | 0.7500 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.60 | 27.76 | 64 | 2235 | 0.0286 | 0.1410 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 32.60 | 27.76 | 1117 | 2235 | 0.4996 | 0.7924 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.30 | 27.76 | 27 | 2449 | 0.0110 | -0.0043 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.30 | 27.76 | 961 | 2449 | 0.3923 | 0.7304 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.30 | 27.76 | 67 | 2449 | 0.0273 | 0.1461 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.30 | 27.76 | 1142 | 2449 | 0.4662 | 0.7773 | MN20160318_Q01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.01 | 27.76 | 30 | 2662 | 0.0113 | 0.0119 | MN20160318_Q01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.01 | 27.76 | 979 | 2662 | 0.3676 | 0.7180 | MN20160318_Q01 | C21 |